In 500 ICU adults with metabolic acidosis receiving vasopressors, sodium bicarbonate did not reduce 30-day major adverse kidney events vs placebo (40.2% vs 39.4%; adjusted difference 1.2 points, P=0.78). In-hospital mortality was 25.4% vs 24.0%.
RCTn = 500
SODa-BIC Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group et al. Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock